- Home
- Publications
- Publication Search
- Publication Details
Title
Biomarkers and surrogate endpoints in kidney disease
Authors
Keywords
Surrogate endpoints, Biomarkers, Acute kidney injury, Chronic kidney disease, End-stage renal disease, Polycystic kidney disease
Journal
PEDIATRIC NEPHROLOGY
Volume 31, Issue 3, Pages 381-391
Publisher
Springer Nature
Online
2015-05-15
DOI
10.1007/s00467-015-3104-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GFR Decline as an End Point in Trials of CKD: A Viewpoint From the FDA
- (2014) Aliza Thompson et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- GFR Decline and Subsequent Risk of Established Kidney Outcomes: A Meta-analysis of 37 Randomized Controlled Trials
- (2014) Hiddo J. Lambers Heerspink et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- GFR Decline as an Alternative End Point to Kidney Failure in Clinical Trials: A Meta-analysis of Treatment Effects From 37 Randomized Trials
- (2014) Lesley A. Inker et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- GFR Decline as an End Point for Clinical Trials in CKD: A Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration
- (2014) Andrew S. Levey et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Effect of Pravastatin on Total Kidney Volume, Left Ventricular Mass Index, and Microalbuminuria in Pediatric Autosomal Dominant Polycystic Kidney Disease
- (2014) M. A. Cadnapaphornchai et al. Clinical Journal of the American Society of Nephrology
- Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality
- (2014) Josef Coresh et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pentraxin 3 as a novel bio-marker of inflammation and endothelial dysfunction in autosomal dominant polycystic kidney disease
- (2014) Ismail Kocyigit et al. JOURNAL OF NEPHROLOGY
- Predictors of Autosomal Dominant Polycystic Kidney Disease Progression
- (2014) R. W. Schrier et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Cell cycle arrest biomarkers win race for AKI diagnosis
- (2014) Zoltán H. Endre et al. Nature Reviews Nephrology
- Biomarkers in Acute Kidney Injury: Are We Ready for Prime Time?
- (2014) Prasad Devarajan et al. NEPHRON CLINICAL PRACTICE
- Clinical Trial Endpoints in Acute Kidney Injury
- (2014) Frederic T. Billings IV et al. NEPHRON CLINICAL PRACTICE
- Defining new surrogate markers for CKD progression
- (2014) H. William Schnaper et al. PEDIATRIC NEPHROLOGY
- Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury: a critical evaluation of current status
- (2014) A. Haase-Fielitz et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Estimated GFR Decline as a Surrogate End Point for Kidney Failure: A Post Hoc Analysis From the Reduction of End Points in Non–Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) Study and Irbesartan Diabetic Nephropathy Trial (IDNT)
- (2013) Hiddo J. Lambers Heerspink et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Net Reclassification Indices for Evaluating Risk Prediction Instruments
- (2013) Kathleen F. Kerr et al. EPIDEMIOLOGY
- Urinary Proteomic Biomarkers for Diagnosis and Risk Stratification of Autosomal Dominant Polycystic Kidney Disease: A Multicentric Study
- (2013) Andreas D. Kistler et al. PLoS One
- A note on the evaluation of novel biomarkers: do not rely on integrated discrimination improvement and net reclassification index
- (2013) Jørgen Hilden et al. STATISTICS IN MEDICINE
- Relationship of Copeptin, a Surrogate Marker for Arginine Vasopressin, With Change in Total Kidney Volume and GFR Decline in Autosomal Dominant Polycystic Kidney Disease: Results From the CRISP Cohort
- (2012) Wendy E. Boertien et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Emergent Early Markers of Renal Progression in Autosomal-Dominant Polycystic Kidney Disease Patients: Implications for Prevention and Treatment
- (2012) Imed Helal et al. AMERICAN JOURNAL OF NEPHROLOGY
- Kidney Volume and Functional Outcomes in Autosomal Dominant Polycystic Kidney Disease
- (2012) A. B. Chapman et al. Clinical Journal of the American Society of Nephrology
- Microalbuminuria as Surrogate Endpoint in Therapeutic Trials
- (2012) Josep Redon et al. CURRENT HYPERTENSION REPORTS
- Proteinuria as a surrogate end point—more data are needed
- (2012) Aliza Thompson Nature Reviews Nephrology
- Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
- (2012) Vicente E. Torres et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biomarkers and surrogate endpoints in clinical trials
- (2012) Thomas R. Fleming et al. STATISTICS IN MEDICINE
- Notice
- (2012) Kidney International Supplements
- Evaluating the Incremental Value of New Biomarkers With Integrated Discrimination Improvement
- (2011) K. F. Kerr et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Debate: CON Position. Should Microalbuminuria Ever Be Considered as a Renal Endpoint in Any Clinical Trial
- (2010) Richard J. Glassock AMERICAN JOURNAL OF NEPHROLOGY
- Debate: PRO Position. Should Microalbuminuria Ever Be Considered as a Renal Endpoint in Any Clinical Trial
- (2010) Hiddo J. Lambers Heerspink et al. AMERICAN JOURNAL OF NEPHROLOGY
- Proteinuria as a Surrogate Outcome in CKD: Report of a Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration
- (2009) Andrew S. Levey et al. AMERICAN JOURNAL OF KIDNEY DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started